Covered recipient · General Payments record
YEVGENIY BUKHMAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$9,880.16
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $3,919.23 | 9 |
| Food and Beverage | $1,166.26 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,895.22 | 3 |
| Amgen Inc. | $1,650.34 | 5 |
| Moderna TX, Inc. | $1,421.35 | 10 |
| Novo Nordisk AS | $118.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $275.00 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115468872 | CMS |
| Amgen Inc. | $55.09 | 02/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115468878 | CMS |
| Amgen Inc. | $562.74 | 02/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115468885 | CMS |
| Amgen Inc. | $63.30 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115468892 | CMS |
| Amgen Inc. | $694.21 | 02/23/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1115468897 | CMS |
| E.R. Squibb & Sons, L.L.C. | $308.03 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101303429 | CMS |
| E.R. Squibb & Sons, L.L.C. | $1,258.82 | 03/29/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1101303431 | CMS |
| E.R. Squibb & Sons, L.L.C. | $328.37 | 03/29/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1101303433 | CMS |
| ModernaTX, Inc. | $95.35 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560796 | CMS |
| ModernaTX, Inc. | $240.00 | 09/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152560798 | CMS |
| ModernaTX, Inc. | $379.95 | 09/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152560804 | CMS |
| ModernaTX, Inc. | $134.52 | 09/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152560806 | CMS |
| ModernaTX, Inc. | $265.53 | 09/14/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152560808 | CMS |
| ModernaTX, Inc. | $120.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560812 | CMS |
| ModernaTX, Inc. | $45.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560814 | CMS |
| ModernaTX, Inc. | $30.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560816 | CMS |
| ModernaTX, Inc. | $81.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560818 | CMS |
| ModernaTX, Inc. | $30.00 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152560820 | CMS |
| Novo Nordisk Inc | $118.58 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097076625 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.